Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients.
The urinary metabolite profile of quinidine and the oral clearance of this drug were studied under steady state conditions in five smoking and nine non-smoking patients. No significant differences were observed in the urinary recovery of unchanged quinidine, 3S-3-hydroxyquinidine, 2'-oxoquinidinone or quinidine-N-oxide between smokers and non-smokers. In addition, the plasma clearance of quinidine was not affected by the smoking status of subjects. These results suggest that cigarette smoke does not induce any of the main pathways for quinidine metabolism in a typical patient population and that the consideration of smoking status is of little utility in aiding in the selection of initial dosage regimens for this drug.
D000368:Aged; D003497:Cyclic N-Oxides / Q000652:urine; D006801:Humans; D007700:Kinetics; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D011802:Quinidine / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism* / Q000652:urine; D012907:Smoking
D003497:Cyclic N-Oxides; C013569:3-hydroxyquinidine; C045112:quinidine-N-oxide; C052071:2'-oxoquinidinone; D011802:Quinidine